EP16.03-002 Mechanisms of Resistance to First-line Osimertinib in Hispanic Patients with EGFR mutant Non-Small Cell Lung Cancer (FRESTON-CLICaP∫)
Chamorro, D.F., Ruiz-Patiño, A., Recondo, G., Martín, C., Raez, L., Samtani, S., Minata, J.N., Blaquier, J.B., Enrico, D., Burotto, M., Ordoñez-Reyes, C., Garcia-Robledo, J.B., Corrales, L., Zatarain-Barrón, L., Más, L., Sotelo, C., Ricaurte, L., Santoyo, N., Cuello, M., Mejia, S., Jaller, E., Vargas, C., Carranza, H., Otero, J., Rodríguez, J., Archila, P., Bermudez, M., Gamez, T., Cordeiro de Lima, V., Freitas, H., Russo, A., Polo, C., Malapelle, U., de Miguel-Perez, D., Rolfo, C., Viola, L., Rossell, R., Arrieta, O., Cardona, A.F.
Published in Journal of thoracic oncology (01.09.2022)
Published in Journal of thoracic oncology (01.09.2022)
Get full text
Journal Article